《新股表現》生興(01472.HK)暗盤開報0.55元 高上市價10%
根據輝立交易平台顯示,明天掛牌的生興控股(01472.HK)暗盤高開10%報0.55元,最高見0.65元,現造0.68元,較上市價0.5元,高36%,成交255萬股。
生興是本港土木工程承建商。是次上市共發售2.5億股,其中10%公開發售獲近1.5倍超購,認購一手中籤率不足76%,股份以招股範圍(0.5-0.63)下限定價,料集資淨額約8,190萬元,主要用作收購額外機器設備、為正在進行及未來地盤平整/道路/渠務工程項目招聘、滿足與將由集團承接額外政府地盤平整/道路/渠務工程合約有關適用營運資金需求等。上市獨家保薦人信達國際。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.